nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—BCHE—Cisplatin—bone cancer	0.522	0.629	CbGbCtD
Nizatidine—ABCB1—Cisplatin—bone cancer	0.133	0.16	CbGbCtD
Nizatidine—ABCB1—Doxorubicin—bone cancer	0.0888	0.107	CbGbCtD
Nizatidine—ABCB1—Methotrexate—bone cancer	0.0861	0.104	CbGbCtD
Nizatidine—Ranitidine—CYP3A4—bone cancer	0.0132	1	CrCbGaD
Nizatidine—Infection—Carboplatin—bone cancer	0.00358	0.0228	CcSEcCtD
Nizatidine—Liver injury—Cisplatin—bone cancer	0.00352	0.0224	CcSEcCtD
Nizatidine—Hyperuricaemia—Cisplatin—bone cancer	0.00319	0.0203	CcSEcCtD
Nizatidine—Pain—Carboplatin—bone cancer	0.00308	0.0196	CcSEcCtD
Nizatidine—Blood uric acid increased—Cisplatin—bone cancer	0.00302	0.0192	CcSEcCtD
Nizatidine—Hepatocellular injury—Cisplatin—bone cancer	0.00296	0.0189	CcSEcCtD
Nizatidine—Body temperature increased—Carboplatin—bone cancer	0.00285	0.0181	CcSEcCtD
Nizatidine—Nasal congestion—Cisplatin—bone cancer	0.00236	0.015	CcSEcCtD
Nizatidine—Irritability—Cisplatin—bone cancer	0.00205	0.0131	CcSEcCtD
Nizatidine—Amblyopia—Epirubicin—bone cancer	0.00197	0.0125	CcSEcCtD
Nizatidine—Nasopharyngitis—Cisplatin—bone cancer	0.00192	0.0122	CcSEcCtD
Nizatidine—Amblyopia—Doxorubicin—bone cancer	0.00182	0.0116	CcSEcCtD
Nizatidine—Liver injury—Epirubicin—bone cancer	0.00181	0.0115	CcSEcCtD
Nizatidine—Hyperuricaemia—Methotrexate—bone cancer	0.00175	0.0112	CcSEcCtD
Nizatidine—Hepatic enzyme increased—Methotrexate—bone cancer	0.00172	0.0109	CcSEcCtD
Nizatidine—Liver injury—Doxorubicin—bone cancer	0.00167	0.0107	CcSEcCtD
Nizatidine—Vasculitis—Methotrexate—bone cancer	0.00166	0.0106	CcSEcCtD
Nizatidine—Blood uric acid increased—Methotrexate—bone cancer	0.00165	0.0105	CcSEcCtD
Nizatidine—Hyperuricaemia—Epirubicin—bone cancer	0.00164	0.0104	CcSEcCtD
Nizatidine—Blood uric acid increased—Epirubicin—bone cancer	0.00155	0.00986	CcSEcCtD
Nizatidine—Ventricular tachycardia—Epirubicin—bone cancer	0.00152	0.00969	CcSEcCtD
Nizatidine—Hepatocellular injury—Epirubicin—bone cancer	0.00152	0.00969	CcSEcCtD
Nizatidine—Hyperuricaemia—Doxorubicin—bone cancer	0.00152	0.00966	CcSEcCtD
Nizatidine—Abnormal dreams—Epirubicin—bone cancer	0.0015	0.00957	CcSEcCtD
Nizatidine—Gynaecomastia—Methotrexate—bone cancer	0.00145	0.00926	CcSEcCtD
Nizatidine—Blood uric acid increased—Doxorubicin—bone cancer	0.00143	0.00913	CcSEcCtD
Nizatidine—Hepatocellular injury—Doxorubicin—bone cancer	0.00141	0.00896	CcSEcCtD
Nizatidine—Ventricular tachycardia—Doxorubicin—bone cancer	0.00141	0.00896	CcSEcCtD
Nizatidine—Abnormal dreams—Doxorubicin—bone cancer	0.00139	0.00886	CcSEcCtD
Nizatidine—Flatulence—Cisplatin—bone cancer	0.00128	0.00813	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Methotrexate—bone cancer	0.00125	0.00796	CcSEcCtD
Nizatidine—Anaemia—Cisplatin—bone cancer	0.0012	0.00762	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Epirubicin—bone cancer	0.00117	0.00745	CcSEcCtD
Nizatidine—Irritability—Methotrexate—bone cancer	0.00113	0.00717	CcSEcCtD
Nizatidine—Convulsion—Cisplatin—bone cancer	0.00112	0.00714	CcSEcCtD
Nizatidine—Myalgia—Cisplatin—bone cancer	0.0011	0.00702	CcSEcCtD
Nizatidine—Anxiety—Cisplatin—bone cancer	0.0011	0.007	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00108	0.0069	CcSEcCtD
Nizatidine—Anaphylactic shock—Cisplatin—bone cancer	0.00106	0.00673	CcSEcCtD
Nizatidine—Infection—Cisplatin—bone cancer	0.00105	0.00669	CcSEcCtD
Nizatidine—Thrombocytopenia—Cisplatin—bone cancer	0.00103	0.00659	CcSEcCtD
Nizatidine—Hyperhidrosis—Cisplatin—bone cancer	0.00102	0.00651	CcSEcCtD
Nizatidine—Eosinophilia—Methotrexate—bone cancer	0.00101	0.00643	CcSEcCtD
Nizatidine—Anorexia—Cisplatin—bone cancer	0.00101	0.00642	CcSEcCtD
Nizatidine—Nasopharyngitis—Epirubicin—bone cancer	0.000987	0.00629	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000963	0.00613	CcSEcCtD
Nizatidine—Eosinophilia—Epirubicin—bone cancer	0.000945	0.00602	CcSEcCtD
Nizatidine—Erectile dysfunction—Methotrexate—bone cancer	0.000939	0.00598	CcSEcCtD
Nizatidine—Decreased appetite—Cisplatin—bone cancer	0.000918	0.00585	CcSEcCtD
Nizatidine—Pneumonia—Methotrexate—bone cancer	0.000914	0.00582	CcSEcCtD
Nizatidine—Nasopharyngitis—Doxorubicin—bone cancer	0.000913	0.00582	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000912	0.00581	CcSEcCtD
Nizatidine—Pain—Cisplatin—bone cancer	0.000903	0.00576	CcSEcCtD
Nizatidine—Eosinophilia—Doxorubicin—bone cancer	0.000874	0.00557	CcSEcCtD
Nizatidine—Sweating—Methotrexate—bone cancer	0.000871	0.00555	CcSEcCtD
Nizatidine—Feeling abnormal—Cisplatin—bone cancer	0.000871	0.00555	CcSEcCtD
Nizatidine—Pneumonia—Epirubicin—bone cancer	0.000856	0.00545	CcSEcCtD
Nizatidine—Body temperature increased—Cisplatin—bone cancer	0.000835	0.00532	CcSEcCtD
Nizatidine—Jaundice—Epirubicin—bone cancer	0.000829	0.00528	CcSEcCtD
Nizatidine—Hepatitis—Methotrexate—bone cancer	0.000816	0.0052	CcSEcCtD
Nizatidine—Sweating—Epirubicin—bone cancer	0.000816	0.00519	CcSEcCtD
Nizatidine—Pharyngitis—Methotrexate—bone cancer	0.00081	0.00516	CcSEcCtD
Nizatidine—Sinusitis—Epirubicin—bone cancer	0.000798	0.00508	CcSEcCtD
Nizatidine—Pneumonia—Doxorubicin—bone cancer	0.000792	0.00504	CcSEcCtD
Nizatidine—Jaundice—Doxorubicin—bone cancer	0.000767	0.00489	CcSEcCtD
Nizatidine—Rhinitis—Epirubicin—bone cancer	0.000766	0.00488	CcSEcCtD
Nizatidine—Hepatitis—Epirubicin—bone cancer	0.000764	0.00486	CcSEcCtD
Nizatidine—Asthenia—Cisplatin—bone cancer	0.000758	0.00483	CcSEcCtD
Nizatidine—Pharyngitis—Epirubicin—bone cancer	0.000758	0.00483	CcSEcCtD
Nizatidine—Sweating—Doxorubicin—bone cancer	0.000755	0.00481	CcSEcCtD
Nizatidine—Sinusitis—Doxorubicin—bone cancer	0.000738	0.0047	CcSEcCtD
Nizatidine—Diarrhoea—Cisplatin—bone cancer	0.000723	0.0046	CcSEcCtD
Nizatidine—Rhinitis—Doxorubicin—bone cancer	0.000708	0.00451	CcSEcCtD
Nizatidine—Hepatitis—Doxorubicin—bone cancer	0.000707	0.0045	CcSEcCtD
Nizatidine—Pharyngitis—Doxorubicin—bone cancer	0.000701	0.00447	CcSEcCtD
Nizatidine—Back pain—Methotrexate—bone cancer	0.000687	0.00438	CcSEcCtD
Nizatidine—Vomiting—Cisplatin—bone cancer	0.000672	0.00428	CcSEcCtD
Nizatidine—Rash—Cisplatin—bone cancer	0.000666	0.00424	CcSEcCtD
Nizatidine—Dermatitis—Cisplatin—bone cancer	0.000666	0.00424	CcSEcCtD
Nizatidine—Anaemia—Methotrexate—bone cancer	0.000657	0.00418	CcSEcCtD
Nizatidine—Flatulence—Epirubicin—bone cancer	0.000655	0.00417	CcSEcCtD
Nizatidine—Tension—Epirubicin—bone cancer	0.000652	0.00416	CcSEcCtD
Nizatidine—Nervousness—Epirubicin—bone cancer	0.000646	0.00411	CcSEcCtD
Nizatidine—Back pain—Epirubicin—bone cancer	0.000643	0.0041	CcSEcCtD
Nizatidine—Nausea—Cisplatin—bone cancer	0.000628	0.004	CcSEcCtD
Nizatidine—Cough—Methotrexate—bone cancer	0.00062	0.00395	CcSEcCtD
Nizatidine—Convulsion—Methotrexate—bone cancer	0.000615	0.00392	CcSEcCtD
Nizatidine—Anaemia—Epirubicin—bone cancer	0.000614	0.00391	CcSEcCtD
Nizatidine—Flatulence—Doxorubicin—bone cancer	0.000606	0.00386	CcSEcCtD
Nizatidine—Chest pain—Methotrexate—bone cancer	0.000605	0.00385	CcSEcCtD
Nizatidine—Myalgia—Methotrexate—bone cancer	0.000605	0.00385	CcSEcCtD
Nizatidine—Tension—Doxorubicin—bone cancer	0.000604	0.00384	CcSEcCtD
Nizatidine—Nervousness—Doxorubicin—bone cancer	0.000597	0.00381	CcSEcCtD
Nizatidine—Back pain—Doxorubicin—bone cancer	0.000595	0.00379	CcSEcCtD
Nizatidine—Confusional state—Methotrexate—bone cancer	0.000585	0.00372	CcSEcCtD
Nizatidine—Cough—Epirubicin—bone cancer	0.00058	0.0037	CcSEcCtD
Nizatidine—Anaphylactic shock—Methotrexate—bone cancer	0.00058	0.00369	CcSEcCtD
Nizatidine—Convulsion—Epirubicin—bone cancer	0.000576	0.00367	CcSEcCtD
Nizatidine—Infection—Methotrexate—bone cancer	0.000576	0.00367	CcSEcCtD
Nizatidine—Anaemia—Doxorubicin—bone cancer	0.000569	0.00362	CcSEcCtD
Nizatidine—Thrombocytopenia—Methotrexate—bone cancer	0.000568	0.00362	CcSEcCtD
Nizatidine—Myalgia—Epirubicin—bone cancer	0.000566	0.00361	CcSEcCtD
Nizatidine—Chest pain—Epirubicin—bone cancer	0.000566	0.00361	CcSEcCtD
Nizatidine—Anxiety—Epirubicin—bone cancer	0.000564	0.00359	CcSEcCtD
Nizatidine—Hyperhidrosis—Methotrexate—bone cancer	0.00056	0.00357	CcSEcCtD
Nizatidine—Dry mouth—Epirubicin—bone cancer	0.000554	0.00353	CcSEcCtD
Nizatidine—Anorexia—Methotrexate—bone cancer	0.000553	0.00352	CcSEcCtD
Nizatidine—Confusional state—Epirubicin—bone cancer	0.000547	0.00348	CcSEcCtD
Nizatidine—Anaphylactic shock—Epirubicin—bone cancer	0.000543	0.00346	CcSEcCtD
Nizatidine—Infection—Epirubicin—bone cancer	0.000539	0.00343	CcSEcCtD
Nizatidine—Cough—Doxorubicin—bone cancer	0.000537	0.00342	CcSEcCtD
Nizatidine—Convulsion—Doxorubicin—bone cancer	0.000533	0.00339	CcSEcCtD
Nizatidine—Thrombocytopenia—Epirubicin—bone cancer	0.000531	0.00338	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000528	0.00336	CcSEcCtD
Nizatidine—Hyperhidrosis—Epirubicin—bone cancer	0.000524	0.00334	CcSEcCtD
Nizatidine—Insomnia—Methotrexate—bone cancer	0.000524	0.00334	CcSEcCtD
Nizatidine—Chest pain—Doxorubicin—bone cancer	0.000524	0.00334	CcSEcCtD
Nizatidine—Myalgia—Doxorubicin—bone cancer	0.000524	0.00334	CcSEcCtD
Nizatidine—Anxiety—Doxorubicin—bone cancer	0.000522	0.00332	CcSEcCtD
Nizatidine—Anorexia—Epirubicin—bone cancer	0.000517	0.00329	CcSEcCtD
Nizatidine—Somnolence—Methotrexate—bone cancer	0.000515	0.00328	CcSEcCtD
Nizatidine—Dry mouth—Doxorubicin—bone cancer	0.000512	0.00326	CcSEcCtD
Nizatidine—Dyspepsia—Methotrexate—bone cancer	0.00051	0.00325	CcSEcCtD
Nizatidine—Confusional state—Doxorubicin—bone cancer	0.000506	0.00322	CcSEcCtD
Nizatidine—Decreased appetite—Methotrexate—bone cancer	0.000504	0.00321	CcSEcCtD
Nizatidine—Anaphylactic shock—Doxorubicin—bone cancer	0.000502	0.0032	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000501	0.00319	CcSEcCtD
Nizatidine—Infection—Doxorubicin—bone cancer	0.000499	0.00318	CcSEcCtD
Nizatidine—Pain—Methotrexate—bone cancer	0.000496	0.00316	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000494	0.00315	CcSEcCtD
Nizatidine—Thrombocytopenia—Doxorubicin—bone cancer	0.000492	0.00313	CcSEcCtD
Nizatidine—Insomnia—Epirubicin—bone cancer	0.000491	0.00313	CcSEcCtD
Nizatidine—Hyperhidrosis—Doxorubicin—bone cancer	0.000485	0.00309	CcSEcCtD
Nizatidine—Somnolence—Epirubicin—bone cancer	0.000482	0.00307	CcSEcCtD
Nizatidine—Anorexia—Doxorubicin—bone cancer	0.000479	0.00305	CcSEcCtD
Nizatidine—Feeling abnormal—Methotrexate—bone cancer	0.000478	0.00304	CcSEcCtD
Nizatidine—Dyspepsia—Epirubicin—bone cancer	0.000478	0.00304	CcSEcCtD
Nizatidine—Gastrointestinal pain—Methotrexate—bone cancer	0.000474	0.00302	CcSEcCtD
Nizatidine—Decreased appetite—Epirubicin—bone cancer	0.000472	0.003	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000468	0.00298	CcSEcCtD
Nizatidine—Pain—Epirubicin—bone cancer	0.000464	0.00296	CcSEcCtD
Nizatidine—Constipation—Epirubicin—bone cancer	0.000464	0.00296	CcSEcCtD
Nizatidine—Urticaria—Methotrexate—bone cancer	0.000461	0.00293	CcSEcCtD
Nizatidine—Abdominal pain—Methotrexate—bone cancer	0.000458	0.00292	CcSEcCtD
Nizatidine—Body temperature increased—Methotrexate—bone cancer	0.000458	0.00292	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000457	0.00291	CcSEcCtD
Nizatidine—Insomnia—Doxorubicin—bone cancer	0.000454	0.00289	CcSEcCtD
Nizatidine—Feeling abnormal—Epirubicin—bone cancer	0.000447	0.00285	CcSEcCtD
Nizatidine—Somnolence—Doxorubicin—bone cancer	0.000446	0.00284	CcSEcCtD
Nizatidine—Gastrointestinal pain—Epirubicin—bone cancer	0.000444	0.00283	CcSEcCtD
Nizatidine—Dyspepsia—Doxorubicin—bone cancer	0.000442	0.00281	CcSEcCtD
Nizatidine—Decreased appetite—Doxorubicin—bone cancer	0.000436	0.00278	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000433	0.00276	CcSEcCtD
Nizatidine—Urticaria—Epirubicin—bone cancer	0.000431	0.00275	CcSEcCtD
Nizatidine—Pain—Doxorubicin—bone cancer	0.000429	0.00273	CcSEcCtD
Nizatidine—Constipation—Doxorubicin—bone cancer	0.000429	0.00273	CcSEcCtD
Nizatidine—Abdominal pain—Epirubicin—bone cancer	0.000429	0.00273	CcSEcCtD
Nizatidine—Body temperature increased—Epirubicin—bone cancer	0.000429	0.00273	CcSEcCtD
Nizatidine—Asthenia—Methotrexate—bone cancer	0.000416	0.00265	CcSEcCtD
Nizatidine—Feeling abnormal—Doxorubicin—bone cancer	0.000414	0.00264	CcSEcCtD
Nizatidine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000411	0.00261	CcSEcCtD
Nizatidine—Pruritus—Methotrexate—bone cancer	0.00041	0.00261	CcSEcCtD
Nizatidine—Urticaria—Doxorubicin—bone cancer	0.000399	0.00254	CcSEcCtD
Nizatidine—Abdominal pain—Doxorubicin—bone cancer	0.000397	0.00253	CcSEcCtD
Nizatidine—Body temperature increased—Doxorubicin—bone cancer	0.000397	0.00253	CcSEcCtD
Nizatidine—Diarrhoea—Methotrexate—bone cancer	0.000397	0.00253	CcSEcCtD
Nizatidine—Asthenia—Epirubicin—bone cancer	0.000389	0.00248	CcSEcCtD
Nizatidine—Pruritus—Epirubicin—bone cancer	0.000384	0.00245	CcSEcCtD
Nizatidine—Dizziness—Methotrexate—bone cancer	0.000383	0.00244	CcSEcCtD
Nizatidine—Diarrhoea—Epirubicin—bone cancer	0.000371	0.00236	CcSEcCtD
Nizatidine—Vomiting—Methotrexate—bone cancer	0.000369	0.00235	CcSEcCtD
Nizatidine—Rash—Methotrexate—bone cancer	0.000366	0.00233	CcSEcCtD
Nizatidine—Dermatitis—Methotrexate—bone cancer	0.000365	0.00233	CcSEcCtD
Nizatidine—Headache—Methotrexate—bone cancer	0.000363	0.00231	CcSEcCtD
Nizatidine—Asthenia—Doxorubicin—bone cancer	0.00036	0.00229	CcSEcCtD
Nizatidine—Dizziness—Epirubicin—bone cancer	0.000359	0.00229	CcSEcCtD
Nizatidine—Pruritus—Doxorubicin—bone cancer	0.000355	0.00226	CcSEcCtD
Nizatidine—Vomiting—Epirubicin—bone cancer	0.000345	0.0022	CcSEcCtD
Nizatidine—Nausea—Methotrexate—bone cancer	0.000344	0.00219	CcSEcCtD
Nizatidine—Diarrhoea—Doxorubicin—bone cancer	0.000343	0.00219	CcSEcCtD
Nizatidine—Rash—Epirubicin—bone cancer	0.000342	0.00218	CcSEcCtD
Nizatidine—Dermatitis—Epirubicin—bone cancer	0.000342	0.00218	CcSEcCtD
Nizatidine—Headache—Epirubicin—bone cancer	0.00034	0.00217	CcSEcCtD
Nizatidine—Dizziness—Doxorubicin—bone cancer	0.000332	0.00211	CcSEcCtD
Nizatidine—Nausea—Epirubicin—bone cancer	0.000322	0.00205	CcSEcCtD
Nizatidine—Vomiting—Doxorubicin—bone cancer	0.000319	0.00203	CcSEcCtD
Nizatidine—Rash—Doxorubicin—bone cancer	0.000317	0.00202	CcSEcCtD
Nizatidine—Dermatitis—Doxorubicin—bone cancer	0.000316	0.00201	CcSEcCtD
Nizatidine—Headache—Doxorubicin—bone cancer	0.000314	0.002	CcSEcCtD
Nizatidine—Nausea—Doxorubicin—bone cancer	0.000298	0.0019	CcSEcCtD
